"Patient Registry Software Market by Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopedic, Drugs, Device), Delivery (On premise, Cloud), Functionality (PHM, HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User - Global Forecast to 2023"
Patient registry software market is slated to exhibit lucrative growth rate. Patient registry software market is expected to reach USD 1.49 billion by 2023 from USD 888.6 million in 2018, at a CAGR of 11.0% during the forecast period (2018-2023).
Succeeding an extensive secondary and primary research on patient registry software and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and challenges in the market dynamics segment. Continued pressure to curtail rising healthcare costs, growing demand to improve care quality, implementation of the Affordable Care Act in the U.S., trend towards value-based care, growing use of patient registry data for post-marketing surveillance, improving HCIT infrastructure and adoption of HCIT solutions such as EMRs and HIE, implementation of government initiatives to build patient registries, and rising awareness of population health management are resulting in robust demand for patient registry software across the globe. However, lack of trained/skilled resources, and privacy and data security related concern may hinder the growth of the patient registry software market to some extent.
In addition, the report further gives an extensive outlook on various end users served by the patient registry software market. These end users include government organizations & third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, and research centers. Apart from end users, the report provides insights on adoption of patient registry software in various type of registries, and functionality segment of the market. Moreover, the study offers a comprehensive analysis of patient registry software market with respect to various software type, pricing model, deployment model, and database type.
Further, an in-depth analysis of the geographic scenario of the industry provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. The geographic analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, and government & private investments. The report identifies North America being the largest market followed by Europe, Asia Pacific, and Rest of World. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.
The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3.5 years (2015-June 2018). The market players employed various strategies to expand their product offerings, global footprint, and augment their market share. The key strategies followed by most companies in the global patient registry software market include agreements, partnerships, & collaborations; new product launches; mergers & acquisitions; and expansion.
Some of the key players contributing to the growth of the patient registry software market include Phytel, Inc. (U.S.) (an IBM Corporation company), Quintiles IMS Holdings, Inc. (U.S.), Liaison Technologies. (U.S.), ImageTrend, Inc. (U.S.), FIGmd, Inc. (U.S.), McKesson Corporation (U.S.) (Change Healthcare), CECity.com Inc. (U.S.) (A Premier, Inc. company), Dacima Software Inc. (U.S.), Global Vision Technologies, Inc. (U.S.), ifa Systems AG, (Germany), Syneos Health (U.S.), M2S, Inc. (U.S.), Optum, Inc (A part of UnitedHealth Group Inc) (U.S.), EVADO Pty. Ltd. (Australia), and Velos, Inc. (U.S.) among several others.
Key questions answered in the report:
Hospitals and medical centers are driving the adoption of Patient Registry Software
- How does the penetration of patient registry software differ among various end users?
- Which are the high growth market segments in terms of registry type, software type, functionality, deployment type, database type, pricing model, and regions/countries?
Population Health Management is the fastest growing application/functionality segment of the Patient Registry Software market
- What factors are propelling the growth of patient registry software market in population health management?
- What factors contribute to the growth of patient registry software in medical research?
The North American region is the largest market for patient registry software and includes various global and local players competing in multiple segments
- Who are the top competitors in this market and what strategies do they employ to gain shares?
- Which product segments of the patient registry software market are expected to offer lucrative growth in the forecast period and why?
- What strategies should the new companies focus to enter this market in order sustain and compete with the established players?
- What are the major drivers, restraints, opportunities, challenges, and trends in the global patient registry software market?
- What are the geographic trends and high growth regions/countries?
Recent new product launches, partnerships, agreement, expansion, acquisitions that have taken place in the patient registry software space
- What companies have recently merged/acquired and how will these unions affect the competitive landscape of the patient registry software space?
- What companies have created partnerships and how will these partnerships promote a competitive advantage?
- Who are the major players in the global patient registry software and what share of the market do they hold?
- Who are the local emerging players in the global patient registry software market and how do they compete with the global players?
Scope of the Report
Market, by Registry type
- Disease Registries
- Cardiovascular Registries
- Diabetes Registries
- Cancer Registries
- Rare Disease Registries
- Asthma Registries
- Chronic Kidney Disease Registries
- Orthopedic Registries
- Others
- Health Service Registries
- Product Registries
- Medical Device Registries
- Drug Registries
Market, by Software Type
- Standalone Software
- Integrated Software
Market, by Pricing Model
- Subscription model
- Ownership model
Market, by Deployment Model
- On-premise models
- Web &Cloud-based models
Market, by Database Type
- Commercial databases
- Public databases
Market, by Functionality
- Population Health Management
- Patient Care Management
- Health Information Exchange
- Point-of-Care
- Product Outcome Evaluation
- Medical Research & Clinical Studies
Market, by End User
- Government Organizations & Third-Party Administrators
- Hospitals and Medical Practices
- Private Payers
- Pharmaceutical, Biotechnology, and Medical Device Companies
- Research Centers
Market, by Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia-Pacific (APAC)
- Japan
- China
- India
- Rest of APAC (RoAPAC)
- Latin America
- Middle East & Africa
Table of Contents
Samples
LOADING...
Executive Summary
The Global Patient Registry Software Market is expected to grow at a CAGR of 11.0% from 2018 to 2023 to reach USD 1.49 billion by 2023, driven by factors such as continued pressure to curtail rising healthcare costs, growing demand to improve care quality, increasing adoption of EHRs and improving health IT infrastructure, growing application of patient registry data in post-marketing surveillance, and increase in the support from government for value-based care and adoption of patient registries. Moreover, growing emphasis on population health management and proliferating accountable care organizations (ACO), emergence of cloud-based patient registry solutions, and shifting focus towards Patient-Powered Research Networks (PPRNs) offer significant growth opportunities for the market players during the forecast period.
The patient registry software market study presents historical market data in terms of value (2016 and 2017), estimated current data (2018), and forecasts for 2023 by registry type (disease registry, health services registry, and product registry), software (standalone, integrated), pricing model (subscription, ownership), deployment model (on premise, web &cloud), database type (commercial, public), functionality (population health management, patient care management, health information exchange, point-of-care, product outcome evaluation, medical research & clinical studies), and end user (government organizations & third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, research centers). The study also evaluates industry competitors and analyzes the market at a regional and country level.
With the rising prevalence of chronic disease conditions such as diabetes, cardiovascular diseases and asthma, there is a growing need for chronic disease registries that can help manage patients proactively. Moreover, increasing number of initiatives are being taken across the globe to build rare disease patient registries to gain a better understanding of rare diseases. Such efforts contribute to the largest share of patient registry software for disease registries.
Standalone software comprised the major market share in 2017 as these are usually less complex, dedicated, cost-effective and simpler to setup than integrated systems. However, with the trend towards integrated care, healthcare organizations would increasingly consider integrating the use of registries into clinicians’ workflows at the point-of-care, and interfacing registries with EHRs. This in turn will drive the integrated patient registry software market at the highest CAGR during the forecast period.
In 2017, on premise solutions captured a major share owing to concerns related to patient data confidentiality and security on remotely managed servers. However, cloud-based solutions are anticipated to grow at a lucrative rate for their real-time data analysis, easy accessibility, flexibility, scalability, and cost-effectiveness.
Application of patient registry software for population health management (PHM) held a significant market share in 2017 and is also expected to continue to grow at the fastest CAGR owing to government initiatives for encouraging value-based care and PHM programs.
Government organizations and TPAs are currently the major end users of patient registry software. However, hospitals and medical practices are expected to be in the spotlight during the forecast period.
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, U.K., France, Italy, Spain, and RoE), Asia-Pacific (Japan, China, India, and RoAPAC), Latin America, and the Middle East & Africa. North America captured a significant share in 2017 and is expected to register the highest CAGR during the forecast period mainly due to presence of major Health IT companies in the U.S., advanced healthcare and health IT infrastructure, rising demand for structured information by healthcare stakeholders, increasing need to curtail healthcare costs, implementation of the ACA in the U.S., and rising focus on population health management. In addition, significant growth in the number of EHRs, Accountable Care Organizations (ACOs) and health information exchange (HIEs) further supports the greater adoption and fastest growth in this region.
The patient registry software market is highly competitive and fragmented with the presence of some large well-established IT companies and several small and emerging vendors. Some of the key players contributing to the growth of the patient registry software market include Phytel, Inc. (An IBM Corporation Company) (U.S.), Quintiles IMS Holdings, Inc. (U.S.), Liaison Technologies. (U.S.), ImageTrend, Inc. (U.S.), FIGmd, Inc. (U.S.), McKesson Corporation (U.S.) (Change Healthcare), CECity.com Inc. (U.S.) (A Premier, Inc. Company) , Dacima Software Inc. (U.S.), Global Vision Technologies, Inc. (U.S.), ifa Systems AG, (Germany), Syneos Health (U.S.), M2S, Inc. (U.S.), Optum, Inc (A part of UnitedHealth Group Inc) (U.S.), EVADO Pty. Ltd. (Australia), and Velos, Inc. (U.S.) among several others. In the recent past, these companies significantly focused on entering into agreements, partnerships, strategic alliances, and collaborations to expand their product and service offerings, strengthen their global footprint, and augment their market shares.
Key questions answered in the report
- Which are the high growth market segments in terms of registry type, software type, pricing model, deployment model, database type, functionality, end users, and region/countries?
- What was the historical market for patient registry software across the globe?
- What are the market forecasts and estimates for the period 2018-2023?
- What are the major drivers, restraints, opportunities, and challenges in the patient registry software market?
- Who are the major players in the patient registry software market?
- What are the recent developments in the patient registry software market?
- What are the different strategies adopted by the major players in the patient registry software market?
- What are the geographical trends and high growth regions/ countries?
- Who are the local emerging players in the patient registry software market and how do they compete with the global players?
Companies Mentioned
- CECity.com Inc. (U.S.) (A Premier Inc. Company)
- Dacima Software Inc. (U.S.)
- FIGmd Inc. (U.S.)
- Global Vision Technologies Inc. (U.S.)
- ifa Systems AG(Germany)
- ImageTrend Inc. (U.S.)
- Liaison Technologies. (U.S.)
- McKesson Corporation (U.S.) (Change Healthcare)
- Optum Inc. (A part of UnitedHealth Group Inc) (U.S.) among others.
- Phytel Inc. (An IBM Corporation Company) (U.S.)
- Quintiles IMS Holdings Inc. (U.S.)
